ARCHIVES

NTP Board Approves Concept For New Mutagenesis Assays

This article is from The Cancer Letter archive.

Vol. 14 No. 01 | January 1, 1988

Download PDF Visit The Full Archive

Related Articles

Phase III Trebananib Trial Fails OS Endpoint In Recurrent Platinum-Resistant Ovarian Cancer

November 28, 2014

Van Potter Wins Bristol-Myers Award

April 24, 1981

Revised Price Equivalent to Lower Dose of Avastin

November 8, 2012

Blacks At 11% Greater Cancer Risk, 27% Higher Mortality, NCI Tell President’s Cancer Panel

March 10, 1989

Steckel Urges AACI to seek Increase In Core Funding

July 17, 1981

DCE Board Approves Recompetition Of Large Support Contracts

March 16, 1990